Cryotreatment against Metastatic Renal Cell Bone Tumour Reduced Multiple Lung Metastases

被引:1
|
作者
Nishida, Hideji [1 ]
Shirai, Toshiharu [1 ]
Hayashi, Katsuhiro [1 ]
Takeuchi, Akihiko [2 ]
Tanzawa, Yoshikazu [1 ]
Mizokami, Atsushi [3 ]
Namiki, Mikio [3 ]
Tsuchiya, Hiroyuki [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan
[2] Kanazawa Univ, Grad Sch Med Sci, Dept Community Traumatol & Orthoped, Kanazawa, Ishikawa 9208641, Japan
[3] Kanazawa Univ, Grad Sch Med Sci, Dept Urol, Kanazawa, Ishikawa 9208641, Japan
关键词
Cryoimmunology; cryotreatment; renal cell carcinoma; immunotherapy; LIQUID-NITROGEN; CARCINOMA; CRYOABLATION; RECONSTRUCTION; AUTOGRAFT; CANCER; TISSUE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastatic renal cell carcinoma (RCC) has a poor response to anticancer chemotherapy and radiotherapy. While immunotherapy and molecular targeted drugs have been used as first-line therapy for RCC metastasis, the response rate to these agents is low. We report the case of a patient with lung and bone metastases of RCC whose lung in disappeared after reconstruction using the resected specimen treated by liquid nitrogen for the bone metastasis. This 60-year-old female had a left RCC with multiple lung metastases and a left femoral bone metastasis at the time of diagnosis. After left nephrectomy followed by immunotherapy, we performed tumour excision and reconstruction with frozen recycled auto graft. The lung metastases had disappeared by 10 months after surgery, while serum levels of interferon-gamma and interleukin-12 had increased. We postulate that the antitumour activity resulted from immunotherapy plus cryotreatment of her bone metastasis and believe that this case supports continued research into immunotherapy for cancer.
引用
收藏
页码:2927 / 2930
页数:4
相关论文
共 50 条
  • [41] Preoperative embolization of bone metastases from renal cell carcinoma
    Chatziioannou, AN
    Johnson, ME
    Pneumaticos, SG
    Lawrence, DD
    Carrasco, CH
    EUROPEAN RADIOLOGY, 2000, 10 (04) : 593 - 596
  • [42] The value of TNM tumour staging and serum alkaline phosphatase levels in predicting the presence of bone metastases in patients with renal cell carcinoma
    George, M. J.
    Buscombe, J.
    Al-Akraa, M.
    JOURNAL OF CLINICAL UROLOGY, 2010, 3 (02) : 59 - 64
  • [43] Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma
    Iacovelli, Roberto
    Santini, Daniele
    Rizzo, Mimma
    Felici, Alessandra
    Santoni, Matteo
    Verzoni, Elena
    Masini, Cristina
    Massari, Francesco
    Calvani, Nicola
    Mosca, Alessandra
    Procopio, Giuseppe
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (7-8): : 263 - 267
  • [44] Lung metastases of renal cell carcinoma: Results of surgical resection
    Fourquier, P
    Regnard, JF
    Rea, S
    Levi, JF
    Levasseur, P
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 11 (01) : 17 - 20
  • [45] Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases
    Matsumoto, Daisuke
    Naiki, Taku
    Naiki-Ito, Aya
    Aoki, Maria
    Kato, Shinji
    Morikawa, Toshiharu
    Shimizu, Nobuhiko
    Gonda, Masakazu
    Umemoto, Yukihiro
    Yasui, Takahiro
    IJU CASE REPORTS, 2025, 8 (01) : 5 - 9
  • [46] Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy
    Yildiz, Ibrahim
    Bilici, Ahmet
    Karadurmus, Nuri
    Ozer, Leyla
    Tural, Deniz
    Kaplan, Mehmet A.
    Akman, Tulay
    Bayoglu, Ibrahim, V
    Uysal, Mukremin
    Yildiz, Yasar
    Tanriverdi, Ozgur
    Yazici, Ozan
    Surmeli, Zeki
    Turhal, Nazim Serdar
    Bavbek, Sevil
    Selcukbiricik, Fatih
    Koca, Dogan
    Basaran, Mert
    TUMORI JOURNAL, 2018, 104 (06): : 444 - 450
  • [47] Metastatic renal cell carcinoma to the temporal bone: case report
    De Vos, C.
    Gerard, J. M.
    Decat, M.
    Gersdorff, M.
    B-ENT, 2005, 1 (01) : 43 - 46
  • [48] Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma
    Reinhold Ramoner
    Andrea Rahm
    Claudia E. Falkensammer
    Nicolai Leonhartsberger
    Martin Thurnher
    Cancer Immunology, Immunotherapy, 2010, 59 : 1141 - 1147
  • [49] A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma
    Harada, Hideyuki
    Shikama, Naoto
    Wada, Hitoshi
    Uchida, Nobue
    Nozaki, Miwako
    Hayakawa, Kazushige
    Yamada, Kazunari
    Nagakura, Hisayasu
    Ogawa, Hirofumi
    Miyazawa, Kazunari
    Katagiri, Hirohisa
    Nakamura, Naoki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (01) : 100 - 105
  • [50] Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
    Dogan, Izzet
    Iribas, Ayca
    Paksoy, Nail
    Vatansever, Sezai
    Basaran, Mert
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S587 - S591